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Abstract
Background: Ghana faces an increasing burden of non-communicable disease with rates of hypertension estimated
as high as 36% in adults. Despite these high rates, hypertension control remains very poor in Ghana (4%). The current
project aims to implement and evaluate a community-based programme to raise awareness, and to improve
treatment and control of hypertension in the Eastern Region of Ghana. In this paper, we present the findings of the
baseline cross-sectional survey focusing on hypertension prevalence, awareness, treatment, and control.
Methods: To evaluate the ComHIP project, a quasi-experimental design consisted of a before and after evaluations are
being implemented in the intervention and comparison districts. A cohort study component is being implemented in
the intervention district to assess hypertension control. Background anthropometric and clinical data collected as part
of the baseline survey were analyzed in STATA Version 11. We examined the characteristics of individuals, associated
with the baseline study outcomes using logistic regression models.
Results: We interviewed 2400 respondents (1200 each from the comparison and intervention districts), although final
sample sizes after data cleaning were 1170 participants in the comparison district and 1167 in the intervention district.
With the exception of ethnicity, the control and intervention districts compare favorably. Overall 32.4% of the study
respondents were hypertensive (31.4% in the control site; and 33.4% in the intervention site); 46.2% of hypertensive
individuals were aware of a previous diagnosis of hypertension (44.7% in the control site, and 47.7% in the intervention
site), and only around 9% of these were being treated in either arm. Hypertension control was 1.3% overall (0.5% in the
comparison site, and 2.1% in the intervention site). Age was a predictor of having hypertension, and so was increasing
body mass index (BMI), waist, and hip circumferences. After adjusting for age, the risk factors with the greatest association
with hypertension were being overweight (aOR = 2.30; 95% CI 1.53–3.46) or obese (aOR = 3.61; 95% CI 2.37–5.51). Older
individuals were more likely to be aware of their hypertension status than younger people. After adjusting for age
people with a family history of hypertension or CVD, or having an unhealthy waist hip ratio, were more likely to be
aware of their hypertension status.
Conclusions: The high burden of hypertension among the studied population, coupled with high awareness, yet very
low level of hypertension treatment and control requires in-depth investigation of the bottlenecks to treatment and
control. The low hypertension treatment and control rates despite current and previous general educational programs
particularly in the intervention district, may suggest that such programs are not necessarily impactful on the health of
the population.
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Background
Available evidence shows raised blood pressure to be
one of the leading causes of cardiovascular disease
(CVD) and deaths globally, with latest estimates at
nearly 10.4 million deaths per year worldwide [1]. The
level of raised blood pressure for which treatments have
been shown to reduce clinical events in randomized
trials is generally accepted as ≥140 systolic mmHg or ≥90
diastolic mm Hg. This level is termed ‘hypertension’ [2].
For individuals diagnosed with hypertension, lowering
blood pressure with drugs reduces the risk of subsequent
cardiovascular events, including a 35–40% reduction in
the risk of stroke and a 20–25% reduction in the risk of
myocardial infarction and heart failure [3–5].
Studies show that the current prevalence of hyperten-
sion in many low- and middle-income countries (LMICs),
particularly in urban societies, is already as high as or
higher than in high-income countries [6–8]. Worldwide
the prevalence of hypertension in adults ranges between
32 and 50%, with evidence suggesting that the prevalence
is increasing in Sub- Saharan Africa [8].
Like many LMICs, Ghana is facing an increasing bur-
den of non-communicable diseases (NCDs), with hyper-
tension at the forefront. The Ghana healthcare system
has traditionally focused on addressing communicable
diseases and maternal and child health challenges. There
is now a great need to build the capacity of existing pub-
lic and private healthcare systems to improve hyperten-
sion screening and management. A decade old report of
the Ghana Ministry of Health (MOH) report showed
hypertension as the second leading cause of outpatient
morbidity in adults older than 45 years [9]. Recent esti-
mates of prevalence of hypertension in Ghana range
from 24 to 28% among women and 20–32% among men
[10–13]. Of note, the overall rates of hypertension from
other local studies [10, 13] are relatively low, in part due
to inclusion of younger participants in samples. Hyperten-
sion, nonetheless, is a serious health problem in Ghana;
common risk factors include increasing body mass index
(BMI), increased salt consumption, family history of
hypertension and excessive alcohol intake [10, 14].
Studies suggest that the majority of individuals with
hypertension are unaware of their status, even fewer are
treated for the condition and only a proportion of those
have their blood pressure (BP) under control (i.e. blood
pressure < 140/90 mmHg) [15, 16]. Awareness of hyper-
tension in Ghana is estimated to range between 16.4 and
54.1% [10, 12, 13, 17] and only 1.7–12.7% in individuals
who have their hypertension under control [10, 12, 17].
In the most recent survey involving a nationally repre-
sentative sample, the level of awareness and treatment
status of women and men classified as hypertensive, was
alarmingly low. More than 6 in 10 women (63%) and 8
in 10 men (86%) having high blood pressure, reported to
be unaware of their condition. Amongst the hypertensive
patients, only 17% of the women and 6% of the men
were treated and controlled [13].
The context of hypertension control in Ghana
Ghana’s national NCD Control Programme (NCDCP),
under the Disease Control Prevention Department, was
established in 1992. The Ghana Health Service (GHS) has
developed various guidelines for NCDs and prioritized
hypertension. The guidelines recommend that all patients
with hypertension be referred for further assessment.
The capacity of the GHS workforce to diagnose and
manage hypertension is low. For instance, while training
on NCD management is incorporated in the basic nurse
education curricula, there is no follow-up in-service
training or specialist training on NCD management for
nurses. Nurses are currently also not expected to
manage hypertension and have to learn on-the-job while
assisting specialists.
In partnership with the GHS and the Ghana Police
Service, FHI 360 developed a facility- and community-
based prevention and screening pilot program for
cardiovascular diseases (CVD) in 2009. The program
included two sites – the Police Hospital, an urban ter-
tiary hospital located in Ghana’s capital city, Accra, and
its surrounding community, and Atua Hospital, a district
hospital serving a semi-urban community. A population-
based Assessment of Biological and Behavioral NCD risk
factors within the pilot communities and a Baseline
Health Facility Assessment were completed. CVD
screening started in mid-August 2011 and included
14,000 patients by May 2012. Counseling and education
on healthy eating and lifestyle were provided alongside
screening, which was supported through mHealth life-
style messages, appointment reminders, and treatment
adherence support. Baseline findings of this pilot indi-
cate that hypertension was an important health problem
in the areas with prevalence of 31.9% among females
and 34.1% among males [18].
The current paper presents baseline data from a
2-year hypertension control project, the Community-
based Hypertension Improvement Project (ComHIP),
which has been introduced in the peri-urban Lower
Maya-Krobo district in the Eastern Region of Ghana.
ComHIP is a community-based program for hypertension
control, based on a public-private partnership, and con-
sisting of three parts: implementation, impact evaluation
and a cost-effectiveness evaluation. The private sector is
engaged through licensed chemical sellers (LCSs), who are
community pharmacists. The program utilizes ICTs and
task shifting to enhance the capacity of the Ghana Health
Service to improve management and control of hyperten-
sion. The various components of ComHIP are presented
in Fig. 1.
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ComHIP is also a public-private partnership between
the Ghana Health services, FHI360 and the Novartis
Foundation, supported by the Ghana School of Public
Health and the London School of Hygiene & Tropical
Medicine. While the overaching goal of ComHIP is to
address the huge burden of hypertension through the
deployment of a community-based model that engages
the private sector public sector, and utilizes information
and communication technologies (ICTs). Such a partner-
ship plus the deployment of innovative technology in-
creases the odds of the project’s success. The current
baseline study presents hypertension prevalence, aware-
ness, treatment, as well as knowledge and the risk fac-
tors associated with hypertension in two Ghanaian
health districts.
Methods
Study design
To evaluate the project, a quasi-experimental study con-
sisting of two parts (cross-sectional surveys, and a co-
hort study) were employed. The cross-sectional surveys
constitute a before and after evaluation at baseline and
endline in the intervention and control districts. The co-
hort study is currently being implemented in the inter-
vention district.
Setting
Intervention district
The community selected for the intervention is Lower
Manya-Krobo District in the Eastern Region of Ghana
(Fig. 2). This site was selected following the unmet need
of hypertension and the existing relationship of FHI360
with the district health authorities and the district
authorities’ commitment to address CVD. A recent
unpublished situational analysis of hypertension in that
same district identified hypertension to be the fourth
reason of hospital admissions in 2014 and the eighth
cause of mortality. The analysis further showed that four
deaths were recorded in hospital for every 100 patients
admitted with hypertension [19].
The district has a population of 89,246 of whom 84%
lives in urban areas. The population is served by two
public hospitals, the Atua Government Hospital and
Akuse Hospital, as well as a mission hospital in Agormanya,
St. Martin’s. There are four public health centers, serving
as primary contact points for health care, referring pa-
tients to hospitals. The district includes six sub-districts,
14 Community-based Health Planning and Services
(CHPS) zones. There are approximately 75 licensed chem-
ical sellers (LCS) in the district.
Comparison district
The comparison district is Akuapem South Municipality
(now Nsawam-Adoagyiri Municipality and Akwapim
South District), selected for its relative similarity with
the intervention district regarding socio-demographic
characteristics (income, employment, education); infra-
structure (roads, clinics, hospitals, distance from
metropolitan area); baseline health profile (disease
prevalence, incidence, morbidity and mortality); develop-
ment activity (private investment, NGO activity, state
demonstrations projects); and level of support from the
local health authority.
According to the 2010 Population and Housing
Census, Akwapim South Municipality has an estimated
population of 123,501, representing 4.7% of the total
population of the Eastern Region. Health facilities in the
municipality are the District hospital, six Health Centres,
two private hospitals, five Functional Community Health
Planning and Services (CHPS) compounds; 35 Demarcated
CHPS compounds, two Mission Hospitals; and one
Orthopedic Centre.
Sample size, participants sampling and summary of field
procedures
For sample size calculations different assumptions about
baseline prevalence, and intervention effects on different
Fig. 1 Components of ComHIP
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outcomes can produce different sample sizes. The main
expected outcome of the ComHIP study is to reduce the
proportion of people with uncontrolled hypertension.
The power and sample sizes were thus calculated for re-
ductions of prevalence of uncontrolled hypertension of
about 3% in the control group and 10% in the interven-
tion group (and for other values). Table 1 shows the
power for the detection of different effect sizes on the
reduction of hypertension.
Within each of the study districts, a random sample of
households was conducted using a four- stage sampling
procedure. First, a purposive sampling technique was
used to select the intervention and comparison districts;
the second stage entailed a systematic selection of
Census Enumeration Areas (EAs) from those two dis-
tricts. That selection was done by the Ghana Statistical
Service (GSS). The third stage entailed a simple random
selection of households. Households were eligible for
inclusion if one or more members were aged 30 years
and above and had lived in the district during the last
12 months. All adults meeting the inclusion criteria in a
selected household would be interviewed; this number
ranged from 1 to 9 adults per household in both
districts, with a median of 1 adult per household. There
were 30 EAs each in the Intervention and Comparison
districts.
Surveys were conducted using an innovative mobile
technology: the Open Data Kit software on mobile
devices. With this technology, data were collected at the
household level. Data collected included demographics,
lifestyle factors, knowledge of risk factors and physical
measurements.
 The primary outcomes of the baseline survey are
hypertension prevalence, awareness, proportion of
patients under treatment, proportion of patients
who have their hypertension under control,
systolic and diastolic BP values. Secondary
outcomes at baseline included knowledge of
hypertension risk factors.
Definitions of outcomes:
Primary outcomes
 Prevalence of hypertension: Number of individuals
in district having a SBP ≥ 140 mmHg or DBP
≥90 mmHg or receiving BP-lowering treatment.
High BP was further defined as
○ Stage one hypertension: SBP ≥ 140
and < 160 mm/Hg, or DBP ≥90 and <100 mm/HG
○ Stage two hypertension: SBP ≥ 160- < 180 mm/Hg
or DBP ≥100- <110 mm/HG
○ Stage three hypertension: SBP ≥ 180 mm/Hg or
DBP ≥110 mm/Hg [2]
 Hypertension awareness: Defined by an individual’s
self-reporting a diagnosis of hypertension, and
found to be hypertensive, or currently taking
anti-hypertensive medication
Fig. 2 Map of the Eastern Region of Ghana highlighting the lower Manya Krobo district and Akuapim South municipality
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 Hypertension treatment: Percent of participants with
hypertension currently under treatment.
 Hypertension control: patients with controlled
hypertension: individuals self-reporting taking the
medicines for hypertension prescribed by a health
professional, and having a BP < 140/90 mmHg.
Secondary outcomes
 Knowledge of hypertension risk factors;
The number of risk factors that each respondent
was able to correctly identify through their own
recall (without having it read to them)
○ having received information on prevention of
hypertension was divided into four categories. 1.
not received information, 2 received information
in community, including from friends/family/
traditional healers/street corners) 3. received
information through the media, 4. received
information from health centres or healthcare
providers.
 Systolic and diastolic blood pressure: baseline levels
(mean and median) of BP.
Demographic data
 To ensure that the two districts were comparable
we looked at basic demographics, including age,
marital status, religion, ethnicity, and level of
education.
Associated risk factors: we analysed risk factors that could
have an association with hypertension, according to the
World Heart Federation roadmap for hypertension [20].
 Physical Activity: number of times per week
participants reported being physically active
 Alcohol consumption: due to issues with the survey
we were only able to define participants as never
consuming alcohol or drinking alcohol at least once
a day
 Salt consumption: as a proxy for salt consumption,
we asked whether participants added salt to food at
the table and whether salt is added during food
preparation. Both of these were divided into the
categories: Never; Rarely; Sometimes; Often and
Always
 Sleep apnoea: as a proxy for sleep apnoea we
included three questions: choking while sleeping,
snoring while sleeping, and snorting or gasping
while sleeping
Table 1 Sample size and power calculations for reduction in hypertension under different assumptions of baseline prevalence,
intervention effect and sample size (per arm per survey)
Baseline prevalence 30% 30% 30% 35% 35% 35%
Improvement in control (A) −3.0% −3.0% −3.0% −3.5% −3.5% −3.5%
Improvement in intervention (B) −9.0% −10.5% −12.0% −10.5% −12.3% −14%
Intervention effect size (B – A): -6% −8% −9% −7% −9% −11%
Power if sample size = 800 51% 71% 86% 61% 81% 93%
Power if sample size = 900 56% 76% 90% 66% 85% 95%
Power if sample size = 1000 60% 80% 92% 71% 88% 97%
Power if sample size = 1100 64% 84% 94% 75% 91% 98%
Power if sample size = 1200 68% 87% 96% 78% 93% 99%
Using type I error in the analysis: alpha= 0.05 0.05 0.05 0.05 0.05 0.05
Expected baseline prevalence in both groups: A= 30% 30% 30% 35% 35% 35%
Expected improvement in control group: B= −3.0% −3.0% −3.0% −3.5% −3.5% −3.5%
Expected improvement in intervention group: C= −9.0% −10.5% −12.0% −10.5% −12.3% −14.0%
Therefore the effect of Intervention is: C-B = -6% −8% −9% −7% −9% −11%
Sample per group per period 1000 1.2 833 53% 72% 87% 63% 82% 94%
Sample per group per period 1100 1.2 917 57% 76% 90% 67% 86% 96%
Sample per group per period 1200 1.2 1000 60% 80% 92% 71% 88% 97%
Sample per group per period 1000 1.4 714 47% 66% 82% 56% 76% 90%
Sample per group per period 1100 1.4 786 50% 70% 85% 60% 80% 92%
Sample per group per period 1200 1.4 857 54% 74% 88% 64% 83% 94%
(A) (B) (C)
(A) = Number sampled; (B) = Desgin effect; (C) = Efective sample size
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 History of hypertension
 Family history of hypertension
 Being overweight: proxy indicators for being
overweight included BMI, mid-upper arm
circumference (MUAC), and waist hip ratio.
Blood pressure measurement
Blood pressure was measured a minimum of three times
by survey interviewers, using as fully automated, digital
devices, the OMRON digital sphygmomanometer.
Interviewers were trained to use the device according to
the manufacturer’s recommended protocol, using rec-
ommended methods and categories from standard
guidelines the World Health Organization-International
Society of Hypertension Guidelines for the Management
of Hypertension [21].
Anthropometric measurements
The anthropometric measurements of weight, height, mid-
upper arm circumference, waist and hip circumference
were measured according to standard procedures [22].
Data analysis
Categorical variables were described with proportions
and continuous variables are summarised with medians,
means, and standard deviations. All baseline data were
recorded per comparison or intervention district, as well
as overall.
Association of variables with outcomes
We examined what characteristics of the individuals
were associated with the primary and secondary out-
come variables of the survey. For each potential explana-
tory variable we created a separate logistic regression
model against the outcomes “hypertension status” and
“hypertension awareness” separately. Each model was re-
peated unadjusted by other variables and adjusted by
age, sex and district. The models for the outcome
“hypertension awareness” were restricted to people with
hypertension only. P value less than 0.05 denotes statis-
tical significance.
Results
Participant characteristics
We interviewed 1200 respondents each from the com-
parison and intervention districts. However, after clean-
ing, 1170 and 1167 surveys respectively from the
comparison district and the intervention district had
complete data for analysis. Demographic data are pre-
sented in Table 2. Other than ethnicity, baseline charac-
teristics were similar between districts. Participants were
overwhelmingly Christian (96.0%), had a mean age of
49 years; 66.0% being between 30 and 54 years. Only
10.0% had never been married, and 25.0% had no formal
education.
Prevalence of hypertension
Table 3 summarizes the prevalence, awareness, treat-
ment and control of hypertension in the intervention
and comparison districts. The prevalence of hyperten-
sion was 32.0% among women and 33.0% among men
(not presented in Table 3). Overall 32.4% of the 2337 in-
dividuals were hypertensive: 18.9% of them presented
with stage one hypertension, 8.2% with stage two and
4.9% with stage three. Two individuals for whom DBP
was recorded to be higher than SBP were excluded.
Hypertension awareness
Participants aware of their hypertension are represented
in Table 3. A total of 46.2% of the hypertensive individ-
uals were aware of their condition (44.7% in the com-
parison district and 47.7% in the intervention district)
(Table 3).
Hypertension treatment and control
The proportion of patients with hypertension who were
under treatment is alarmingly low: only between 5 and
14% of hypertension patients in the comparison district,
and between 5.6 and 14.5% in the intervention district
reported to be treated for hypertension. Of those, the in-
dividuals who had their hypertension under control was
1.3% (95% CI 0.7% - 2.5%), with only 0.5% of the patients
in the comparison district (0.1–2.2%) and 2.1% of the
patients in the intervention district (1–4.2%) controlled
for hypertension. For those patients who reported to be
currently treated, hypertension control was higher at
32.3% (14.3% in the comparison site, and 47.1% in the
intervention site). However, the number of patients
under treatment was very low, while the 95% confidence
intervals are wide and overlapping (Table 3).
Knowledge and prevalence of biological and behavioural
risk factors for hypertension
Tables 2 3, and 4 present knowledge and prevalence of
risk factors for hypertension, prevalence of selected behav-
ioral and biological risk factors of hypertension, as well as
other variables. Only 5.7% of the participants from the
comparison district, and 8.6% in the intervention district
knew three or more of the eight known risk factors. The
proportion of people who were aware of one risk factor
was 19% in the comparison district, and 16% in the inter-
vention district, while 63% in the comparison and 58% in
the intervention district unfortunately knew none of the
risk factors (Table 3). Participants’ knowledge of alcohol
consumption, lack of exercise, and insufficient fruit
and vegetables as risk factors for hypertension are
presented in Table 3. Participants from both intervention
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Table 2 Knowledge of risk factors of hypertension in intervention and comparison districts
Knowledge of risk factors
Comparison district Intervention district Overall
Number of risk factors respondent knows
0 585 63.2% 479 58.4% 1064 60.1%
1 172 18.6% 129 15.7% 301 17.3%
2 115 12.4% 141 17.2% 256 14.7%
3 35 3.8% 51 6.2% 86 4.9%
4 12 1.3% 14 1.7% 26 4.9%
5 3 0.3% 4 0.5% 26 1.5%
6 2 0.2% 1 0.1% 7 0.4%
7 0 0.0% 0 0.0% 3 0.2%
8 1 0.1% 1 0.1% 2 0.1%
Knows alcohol as a risk factor Comparison Intervention Overall
No 779 66.6% 666 57.1% 1445 61.8%
Yes 146 12.5% 154 13.2% 300 12.8%
N/A 245 20.9% 347 29.7% 592 25.3%
Knows lack of exercise as a risk factor
No 891 76.1% 775 66.4% 1666 71.3%
Yes 34 2.9% 45 3.9% 79 3.4%
N/A 245 20.9% 347 29.7% 592 25.3%
Knows lack of fruit as a risk factor
No 917 78.4% 806 69.1% 1723 73.7%
Yes 8 0.7% 14 1.2% 22 0.9%
N/A 245 20.9% 347 29.7% 592 25.3%
Knows lack of vegetable as a risk factor
No 917 78.4% 805 69.0% 1722 73.7%
Yes 8 0.7% 15 1.3% 23 1.0%
N/A 245 20.9% 347 29.7% 592 25.3%
Knows salt as a risk factor
No 830 70.9% 719 61.6% 1549 66.3%
Yes 95 8.1% 101 8.7% 196 8.4%
N/A 245 20.9% 347 29.7% 592 25.3%
Knows obesity as a risk factor
No 896 76.6% 794 68.0% 1690 72.3%
Yes 29 2.5% 26 2.2% 55 2.4%
N/A 245 20.9% 347 29.7% 592 25.3%
Received messages about heart health
Received none 320 34.7% 336 41.9% 656 38.0%
In community 108 11.7% 92 11.5% 200 11.6%
Through media 319 34.6% 207 25.8% 526 30.5%
Health centre or doctor 176 19.1% 167 20.8% 343 19.9%
How important to you is lowering the salt/sodium in your diet
Not at all important 111 9.5% 134 11.5% 245 10.5%
Somewhat important 217 18.6% 260 22.4% 477 20.5%
Very important 836 71.8% 769 66.1% 1605 69.0%
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and comparison districts demonstrated similarly low
knowledge of the behavioural risk factors for hypertension.
In Table 2, prevalence of behavioral and biological risk
factors for hypertension are summarized. The majority
of the participants was identified as non- alcohol users
(88.7% in the intervention district and 90.1% in the
control district). BMI was normal in 45.2% of the partici-
pants in the intervention district and 46.3% in the com-
parison district, while 7.3% of the respondents from
both sites was underweight and 19.0% obese.
Biological and behavioural risk factors for hypertension
Figures 3, 4 and 5 represent the different factors associ-
ated with hypertension. Bivariate/unadjusted regression
estimates are presented together with measures adjusted
for age, gender and district. Age was a predictor of
having hypertension; similarly, the odds of being hyper-
tensive tended to increase with increasing BMI and
waist- and hip circumference. Those with a family his-
tory of hypertension or NCD and participants who
smoked also had higher odds of being hypertensive. The
multiple logistic regression model examined predictors
of hypertension after adjusting for a number of covari-
ates. When adjusted for age, risk factors with the great-
est association with hypertension were being overweight
(aOR = 2.30; 95% CI 1.53–3.46) or obese (aOR = 3.61; 95%
CI 2.37–5.51), although significant associations were also
observed with increased waist/hip ratio (aOR = 1.43; 95%
CI 1.30–157), MUAC (aOR = 1.47; 95%CI 1.34–1.62), high
waist circumference (aOR = 1.47; 95% CI 1.34–1.61), and
having some sort of sleep disturbance (aOR = 1.51; 95% CI
1.21–1.87) (Fig. 3).
Figure 4 presents factors associated with hypertension
awareness, adjusted for age. In unadjusted models, older
individuals were more likely to be aware of their
hypertension status than younger people. When adjusted
for age, sex, and district people with a family history of
hypertension (aOR = 2.98; 95% CI 1.20–7.40), or CVD
(aOR = 1.71; 95% CI 1.17–2.52), or with a high waist hip
ratio (aOR = 1.94; 95% CI 1.44–2.63), were more likely
to be aware of their hypertension status. Figure 5 com-
pares the primary outcome of hypertension awareness,
adjusted by age. There were no significant differences
for the primary outcome hypertension awareness by
study site.
Discussion and conclusions
This baseline survey aimed to assess the prevalence,
awareness, and risk factors of hypertension in two
Ghanaian districts prior to the implementation of a
community-based intervention to improve the manage-
ment of hypertension. Prevalence of hypertension in the
comparison district was 31.4% (95% CI 28.7.0–34.1) and
33.4% (95% CI 30.7–36.2) in the intervention district. Less
than 50% of the patients with hypertension were aware of
their condition and the proportion of patients under treat-
ment was alarmingly low. Both the level of hypertension
control and in-depth knowledge of the risk factors for
hypertension were very low (Tables 2 and 3).
Study site differences
Overall the findings in our two study sites were very
similar. Descriptive analysis suggested that individuals
in the intervention district may have had more ex-
posure to educational information about heart health,
and an overall greater awareness of risk factors. This
may be because of FHI 360 s previous efforts in the
area as in 2009 a facility- and community-based
CVD prevention and screening project was imple-
mented in the district hospital aiming to strengthen
Table 3 Hypertension prevalence, awareness, treatment and control in the intervention and comparison districts
Comparison Intervention Total
N % 95% CI N % 95% CI N % 95% CI
Examined 1170 100% 1167 100% 2337 100%
Normal 805 68.8% (66% – 71.4%) 785 67.3% (64.5% – 69.9%) 1590 68.0% (66.1% – 69.9%)
Stage 1 232 19.8% (17.6% – 22.3%) 210 18.0% (15.9% – 20.3%) 442 18.9% (17.4% – 20.6%)
Stage 2 86 7.4% (6% – 9%) 105 9.0% (7.4% – 10.8%) 191 8.2% (7.1% – 9.4%)
Stage 3 47 4.0% (3% – 5.3%) 67 5.7% (4.5% – 7.3%) 114 4.9% (4.1% – 5.9%)
Examined 1170 1167 2337
Hypertensive (1) 367 31.4% (28.7% – 34.1%) 390 33.4% (30.7% – 36.2%) 757 32.4% (30.5% – 34.3%)
Aware (2) 164 44.7% (39.5% – 49.9%) 186 47.7% (42.7% – 52.8%) 350 46.2% (42.6% – 49.9%)
Treated (2) 14 3.8% (2.2% – 6.5%) 17 4.4% (2.6% – 7%) 31 4.1% (2.8% – 5.8%)
% of Aware 8.5% (4.9% – 14.2%) 9.1% (5.6% – 14.5%) 8.9% (6.2% – 12.5%)
Controlled (2) 2 0.5% (0.1% – 2.2%) 8 2.1% (1% – 4.2%) 10 1.3% (0.7% – 2.5%)
% Treated 14.3% (2.5% – 43.8%) 47.1% (23.9% – 71.5%) 32.3% (17.3% – 51.5%)
Comparison districts: (1) % over examined individuals, (2) % over hypertensive individuals
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Table 4 Prevalence of selected behavioral and biological risk factors of hypertension
Physical activity
Times per week Comparison Intervention Overall
0 711 62.2% 679 61.1% 1390 61.6%
1 56 4.9% 46 4.1% 102 4.5%
2 60 5.2% 41 3.7% 101 4.5%
3 65 5.7% 76 6.8% 141 6.3%
4 43 3.8% 28 2.5% 71 3.2%
5 61 5.3% 61 5.5% 122 5.4%
6 36 3.2% 40 3.6% 76 3.4%
7 112 9.8% 140 12.6% 252 11.2%
Alcohol consumption
Never Drink 1032 88.7% 1029 90.1% 2061 89.5%
Drink once a day+ 131 11.3% 112 9.8% 243 10.6%
Salt
Do you add salt to food at table
Never 805 68.8% 581 49.8% 1386 59.3%
Rarely 54 4.6% 94 8.1% 148 6.3%
Sometimes 196 16.8% 297 25.5% 493 21.1%
Often 72 6.2% 120 10.3% 192 8.2%
Always 43 3.7% 75 6.4% 118 5.1%
Is salt added during food preparation
Never 59 5.0% 18 1.5% 77 3.3%
Rarely 17 1.5% 11 0.9% 28 1.2%
Sometimes 47 4.0% 42 3.6% 89 3.8%
Often 247 21.1% 200 17.1% 447 19.1%
Always 800 68.4% 896 76.8% 1696 72.6%
Snoring while sleeping
Rarely or never 947 82.4% 908 80.2% 1855 81.3%
More than once a week 202 17.6% 224 19.8% 426 18.7%
*Total 2281
Snorting or gasping while sleeping
Rarely or never 1027 89.1% 971 86.5% 1998 87.8%
More than once a week 126 10.9% 152 13.5% 278 12.2%
*total 2276
Any sleep problem
Rarely or never 928 80.0% 891 77.8% 1819 78.9%
More than once a week 232 20.0% 254 22.2% 486 21.1%
Previous history
Any previous diagnosis of hypertension
None 869 74.3% 71.2% 1700 72.7%
Previous diagnosis 275 23.5% 27.4% 595 25.5%
Do not know 24 2.1% 1.3% 39 1.7%
No response 2 0.2% 0.1% 3 0.1%
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the capacity of facilities to manage CVD. The project
also implemented facility and community-based primary
and secondary prevention activities, and engaged
policy makers in the prevention of CVD and NCDs
in general. mHealth technology provided patients with
information on healthy lifestyles and adherence to
NCD treatment [18].
The largest demographic difference between the
comparison and intervention sites was ethnic group,
with the majority in the comparison district defining
themselves as Akan, and of the majority in the interven-
tion group as Krobo/Ga/Dangbe. Although belonging to
two distinct ethnic groups, both are located within the
same ecological zone and do not differ significantly in
their health seeking behaviour or practices [23, 24].
Participant characteristics
In line with the Ghana National Strategy for the
Management, Prevention and Control of Chronic Non-
Communicable Diseases 2012–2016, this study focused
on adults aged 30 years or more. The PURE study
included a comparable age group between 35 and
70 years [15] coming from both high and low-and mid-
dle income countries. Other previous studies [10–12] all
involved Ghanaian men and women aged between 25
and 102 years. The 2014 Ghana Demographic and
Health Survey (DHS) was a representative survey look-
ing at hypertension [13]: although the survey is focusing
on 15–49 year olds, the age band 30–49 years permits
comparisons with our study. Our prevalence findings of
20.1/19.6% males/females with hypertension is similar to
that found in the DHS of 23.5/20.1% males/females. The
estimated hypertension prevalence in our baseline survey
is comparable with that of previous local and international
studies. The PURE study [15] reported an overall preva-
lence of 40.8% (40.7% for HICs, 49.7% for UMICs, 39.9%
for LMICs, and 32.2% for LICs), while hypertension preva-
lence from local studies involving men and women in
similar age groups were comparable with our findings
(Table 3). Our prevalence estimates are substantially
higher than the most recent DHS (2014) survey and lower
than those found by Lloyd-Sherlock [17]. This is, however,
not surprising given that the DHS survey included individ-
uals for 15–49 and the Lloyd-Sherlock [17] only included
adults over 50. Our data compare with those of a 2009 fa-
cility- and community-based CVD prevention and screen-
ing project implemented in the intervention district: about
one-in-five (22%) of those screened were pre-hypertensive
(systolic 120–139, diastolic 80–89) and 33% were hyper-
tensive (systolic ≥140, diastolic ≥90) [18]). Our estimated
prevalence of hypertension is consistent with reported
prevalence in other parts of Africa [8, 25], such as in the
neighboring cities of Abidjan in 2005 and Cotonou in
2007, the prevalence was 21.7% and 27.3% respectively
[26]. Higher prevalence was however reported in semi-
urban Nigeria (37%) [25], Burkina Faso (40%) [27] and
Niger (42%) [26].
We estimated that only between 42.6 and 50% of the
people with hypertension were aware of their condition,
while PURE reported an overall awareness of 46.5%
(49.0% for HICs, 52.5% for UMICs, 43.6% for LMICs,
and 40.8% for LICs). The level of awareness in our study
was higher than in most previous studies in Ghana
(Table 5), but disparity in age, as well as setting pecu-
liarity may explain the differences.
Compared to PURE, the overall self-reported treat-
ment and control rates in our study were only 31 of 757
hypertensive individuals (14 from the comparison
district, and 17 from the intervention district). Among
the treated hypertension patients, the control rate was
9% overall, with 14.3% in the control arm and 47.1% in
the intervention. In the Ghana DHS only 11.5% of
hypertensives under treatment were reported to have
their hypertension under control [13].
Associations with risk factors
Supportive of previous studies [10–12, 28], our study
showed that age, BMI, and biological factors were
Table 4 Prevalence of selected behavioral and biological risk factors of hypertension (Continued)
Family history High Blood Pressure
No 669 57.2% 570 48.8% 1239 53.0%
Yes 364 31.1% 460 39.4% 824 35.3%
Not Sure 137 11.7% 137 11.7% 274 11.7%
BMI
Mean 25.4 (25.1, 25.8) 25.5 (25.2, 25.9) 25.5
Median 24.57 24.54 24.6
Underweight 85 7.3% 85 7.3% 170 7.3%
Normal 529 45.2% 540 46.3% 1069 45.7%
Overweight 336 28.7% 321 27.5% 657 28.1%
Obese 220 18.8% 221 18.9% 441 18.9%
Lamptey et al. BMC Public Health  (2017) 17:368 Page 10 of 16
positively associated with both hypertension status and
awareness of the condition. Older individuals, females,
people with a family history of CVD and with unhealthy
hip/waist ratios were more likely to be aware of their
hypertension status. Age, increasing BMI and waist hip
circumference were predictors of having hypertension.
Fig. 3 Factors associated with hypertension status, adjusted for age, sex and district
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This was a community-based study with a sample size
of over 2000 individuals, one of the largest studies of its
kind in the region. This study is part of a larger, mixed-
methods evaluation of community based hypertension
control project, and will be followed up with a second
similar sized cross sectional survey. However, as with
Fig. 4 Associations between hypertension risk factors and hypertension awareness, adjusted by age, sex and district
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any survey there are some potential limitations of the
data collected. Due to safety issues data collectors were
only able to visit households during daylight hours, and
as a result some adults were at work when they visited
the house. To minimize this, collectors would come
back to houses on multiple occasions. This issue seems
however to be similar in both the comparison and inter-
vention districts.
Study implications and future research
The results of this baseline survey have implications for
the intervention being implemented and for future re-
search. The high burden of hypertension among the stud-
ied population, coupled to the relatively high level of
awareness yet very low levels of hypertension treatment
and control requires in-depth investigation of the
bottlenecks to treatment and control. Secondly, the low
treatment and control rates despite current and previous
general educational programs in the intervention district,
are suggestive that such programs are not really impactful
health service delivery strategies. The RODAM study re-
ported hypertension prevalence among rural Ghanaian
women/men to be 32.1% 25.5% respectively, and higher
among urbanized populations (37.9% 38.2% respectively)
[29]. The progressive rise of hypertension as Ghanaians be-
come more urbanized in Berlin, London and Amsterdam,
even in the presence of more sophisticated health care,
show that Ghanaians continue to be at risk of uncontrolled
hypertension. It may therefore be argued that attitude/
behaviour is as important as access, if not more so.
These are important findings for the ongoing interven-
tion. The lack of in-depth knowledge of hypertension
Fig. 5 Factors associated with hypertension awareness, adjusted by age and sex divided by district
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Table 5 Demographic characteristics of participants in intervention and comparison districts
Comparison Intervention Overall
Demographics 1170 1167 2337
Numbers in survey
Age std dev std dev std dev
Mean 49.6 14.9 49.4 15.5 49.5 15.2
Median 47 46 46
Number of adults per age category
30–44 508 43.4% 518 44.4% 1026 43.9%
45–54 264 22.6% 239 20.5% 503 21.5%
55–64 186 15.9% 193 16.5% 379 16.2%
65+ 212 18.1% 217 18.6% 429 18.4%
# Adults per HH
Range 1, 9 1, 9 1,9
Mean 1.6 1.3 1.4
Median 1 1 1
Sex
% male 35.5% 36.5% 36.0%
Marital status
Never married 117 10.0% 152 13.0% 269 11.5%
Living together 59 5.0% 72 6.2% 131 5.6%
Married 647 55.3% 641 54.9% 1288 55.1%
Widowed 166 14.2% 179 15.3% 345 14.8%
Divorced/separated 181 15.5% 123 10.5% 304 13.0%
Religion
Christian 1120 95.7% 1119 95.6% 2239 95.8%
Muslim 12 1.0% 21 1.8% 33 1.4%
Traditional/Spiritualist 13 1.1% 15 1.3% 28 1.2%
No religion 18 1.5% 9 0.8% 27 1.2%
Other 7 0.6% 3 0.3% 10 40.0%
Ethnicity
Akan 945 80.8% 47 4.0% 992 42.5%
Krobo/Ga/Dangbe 78 6.7% 882 75.6% 960 41.1%
Ewe 113 9.7% 218 18.7% 331 14.2%
Grussi 13 1.1% 2 0.2% 15 0.6%
Mole-Dagbani 3 0.3% 3 0.3% 6 0.3%
Hausa 5 0.4% 8 0.7% 13 0.6%
Other 13 1.1% 7 0.6% 20 0.9%
Level of education
No formal education 285 24.4% 314 26.9% 599 25.6%
Less than Primary 202 17.3% 182 15.6% 384 16.4%
Completed primary 210 18.0% 196 16.8% 406 17.4%
Some secondary 315 26.9% 283 24.3% 598 25.6%
Completed secondary 105 9.0% 117 10.0% 222 9.5%
Tertiary Completed post- graduate 50 4.3% 73 6.3% 123 5.3%
Not sure 2 0.2% 0 0.0% 2 0.1%
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risk factors and the high burden of biological risk factors
of hypertension, particularly obesity, will be notable
challenges for the intervention to have its desired impact.
The project’s next steps include an in-depth mapping
of individuals with hypertension by census enumeration
areas. The key findings of the survey have been shared
with the program Technical and Steering Committees,
to optimize targeting of interventions. The implementa-
tion of the program is currently being carried out. The
endline survey will be conducted in 2017, to evaluate the
change in hypertension prevalence, awareness, treatment
and control between the two districts. Using individual
patient data, we will apply logistic regressions for each
of these outcomes including the district and survey
period baseline / endline variables and look at their
interaction; we will also adjust for age. Given that the
observed awareness at baseline in either group was
about 46%, a sample size of 1150 individuals in each
group in the end line survey will provide about a 85%
power to detect a difference of 10% between groups. It
will also provide a more than 90% power to detect a dif-
ference of 7% in treatment coverage in people aware of
hypertension (versus a baseline of about 9%), and a 87%
power to detect a difference of 10% in the proportion of
patients under treatment who have their BP under con-
trol (versus a baseline of about 32%).
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